AU7754901A - Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses - Google Patents

Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses

Info

Publication number
AU7754901A
AU7754901A AU7754901A AU7754901A AU7754901A AU 7754901 A AU7754901 A AU 7754901A AU 7754901 A AU7754901 A AU 7754901A AU 7754901 A AU7754901 A AU 7754901A AU 7754901 A AU7754901 A AU 7754901A
Authority
AU
Australia
Prior art keywords
necroses
tumours
plaques
imaging
representation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU7754901A
Inventor
Johannes Dr Platzek
Peter Mareski
Ulrich Niedballa
Bernd Dr Raduchel
Hanns-Joachim Weinmann
Bernd Misselwitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10040380A external-priority patent/DE10040380B4/en
Application filed by Schering AG filed Critical Schering AG
Publication of AU7754901A publication Critical patent/AU7754901A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU7754901A 2000-08-11 2001-07-23 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses Pending AU7754901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040380A DE10040380B4 (en) 2000-08-11 2000-08-11 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties
PCT/EP2001/008498 WO2002013874A2 (en) 2000-08-11 2001-07-23 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses

Publications (1)

Publication Number Publication Date
AU7754901A true AU7754901A (en) 2002-02-25

Family

ID=7652860

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001277549A Ceased AU2001277549B2 (en) 2000-08-11 2001-07-23 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
AU7754901A Pending AU7754901A (en) 2000-08-11 2001-07-23 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001277549A Ceased AU2001277549B2 (en) 2000-08-11 2001-07-23 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses

Country Status (26)

Country Link
EP (1) EP1307236A2 (en)
JP (1) JP2004506025A (en)
KR (1) KR20030022387A (en)
CN (1) CN1469757A (en)
AR (1) AR034139A1 (en)
AU (2) AU2001277549B2 (en)
BG (1) BG107542A (en)
BR (1) BR0113188A (en)
CA (1) CA2419223A1 (en)
CZ (1) CZ2003392A3 (en)
DE (1) DE10066210B4 (en)
EE (1) EE200300061A (en)
HR (1) HRP20030173A2 (en)
HU (1) HUP0300736A3 (en)
IL (1) IL154385A0 (en)
MX (1) MXPA03001287A (en)
NO (1) NO20030604L (en)
NZ (1) NZ523932A (en)
PL (1) PL365596A1 (en)
RU (1) RU2290206C2 (en)
SK (1) SK1572003A3 (en)
TW (1) TWI296931B (en)
UA (1) UA82642C2 (en)
WO (1) WO2002013874A2 (en)
YU (1) YU10603A (en)
ZA (1) ZA200301949B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (en) * 2002-07-10 2006-10-05 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the presentation of intravascular thrombi
DE102005008309A1 (en) * 2005-02-17 2006-08-24 Schering Ag Pharmaceutical agents containing fluoroalkyl-containing metal complexes and epothilones
DE102006021495A1 (en) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Use of metal chelate containing perfluorinated alkyl-residue, chelator-residue and metal ion equivalent to the atomic number, for the production of diagnostic agent for representation of amyloid-containing plaques
US7887835B2 (en) * 2006-09-19 2011-02-15 Fujifilm Corporation Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound
DE102006049821A1 (en) * 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues
DE102007015598A1 (en) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Use of fluorochemical compounds for diagnostic purposes using imaging techniques
JP2011190183A (en) * 2010-03-11 2011-09-29 Noguchi Institute Fluorous sugar-bonded crown ether derivative
US9976072B2 (en) 2014-03-26 2018-05-22 Chevron U.S.A. Inc. Multicarboxylate compositions and method of making the same
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN109715597A (en) 2016-09-14 2019-05-03 大金工业株式会社 Fluorochemical containing branch
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CA3120665A1 (en) 2018-11-23 2020-05-28 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
CN109867635A (en) * 2019-02-14 2019-06-11 华东师范大学 A kind of T1 type micella magnetic resonance imaging contrast and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
JPH10112939A (en) * 1996-10-07 1998-04-28 Nec Corp Power switching circuit
DE19729013A1 (en) * 1997-07-03 1999-02-04 Schering Ag Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis

Also Published As

Publication number Publication date
ZA200301949B (en) 2004-12-14
BR0113188A (en) 2003-06-24
EE200300061A (en) 2004-12-15
WO2002013874A8 (en) 2002-06-13
SK1572003A3 (en) 2003-10-07
YU10603A (en) 2006-05-25
HUP0300736A3 (en) 2010-01-28
EP1307236A2 (en) 2003-05-07
IL154385A0 (en) 2003-09-17
WO2002013874A2 (en) 2002-02-21
JP2004506025A (en) 2004-02-26
NZ523932A (en) 2007-07-27
MXPA03001287A (en) 2003-10-06
BG107542A (en) 2003-09-30
NO20030604D0 (en) 2003-02-07
CN1469757A (en) 2004-01-21
CA2419223A1 (en) 2003-02-11
UA82642C2 (en) 2008-05-12
RU2290206C2 (en) 2006-12-27
DE10066210B4 (en) 2008-02-28
HRP20030173A2 (en) 2005-04-30
AU2001277549B2 (en) 2007-02-08
TWI296931B (en) 2008-05-21
KR20030022387A (en) 2003-03-15
AR034139A1 (en) 2004-02-04
NO20030604L (en) 2003-04-11
CZ2003392A3 (en) 2003-09-17
HUP0300736A2 (en) 2003-09-29
PL365596A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
IL259724B (en) 40-o-(2-hydroxyethyl)-rapamycin for use in combination with an aromatase inhibitor for the treatment of breast tumors
SI1757606T1 (en) Xanthinderivatives for use as medical agents and the preparation thereof
IL154385A0 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
PL367188A1 (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
IT1313599B1 (en) METALLIC COMPLEXES USABLE IN THE CATALYSIS FOR THE (CO) POLYMERIZATION OF ALPHA-OLEFINS
AU2001277549A1 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
AU2002339157A1 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
PL366421A1 (en) Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
PL368458A1 (en) Improved use of antitumoral compound in cancer therapy
EP1482985A4 (en) Technetium-dipyridine complexes, and methods of use thereof
HUP0400997A3 (en) Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
EP1390689A4 (en) Reducing coherent artifacts in an interferometer
AU9373501A (en) Use of antibodies against specific mhc-peptide complexes
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
PL365482A1 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
AU2003281146A1 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of intravascular thrombes
HUP0400262A3 (en) Glycopeptides, their preparation and use in the treatment of multiple sclerosis
IL152388A0 (en) Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
EP1383543A4 (en) Use of biomolecular targets in the treatment and visualization of brain tumors
AU2002241628A1 (en) Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
GB0022081D0 (en) Pyrazolone lanthanide complexes
GB0106316D0 (en) Apparatus for use in the treatment of hair
EP1677958A4 (en) Slurries containing iron compounds used in the casting of metals
IL146655A0 (en) The use of leptin in fertility